Journal
JOURNAL OF PROTEOME RESEARCH
Volume 8, Issue 2, Pages 643-650Publisher
AMER CHEMICAL SOC
DOI: 10.1021/pr8007495
Keywords
Lectins; affinity chromatography; glycoproteomics; glycoproteins; aberrant glycosylation; breast cancer; plasma; diversity; post-translational modifications; quantification; iTRAQ; HPA; LEL; AAL; LCA
Categories
Funding
- NCI NIH HHS [1U24CA126480] Funding Source: Medline
Ask authors/readers for more resources
Lectin affinity chromatography using concanavalin A (Con A), Helix pomatia, agglutinin (HPA), Lycopersicon esculentum lectin (LEL), Aleuria aurantia lectin (AAL) and Lens culinaris agglutinin (LCA) was used to investigate the utility of narrow selectivity lectins in the characterization of plasma glycoproteome diversity and to recognize cancer associated aberrations in glycosylation. Following affinity chromatographic selection, proteins were tryptically digested, the peptide fragments separated by reversed phase chromatography (RPC), and fractions from RPC identified by tandem mass spectrometry. The diversity of glycosylation found with narrow selectivity lectins was generally 2/3 that of Con A and not related to protein abundance. Small groups of proteins were found with each of the affinity columns, HPA, LEL, AAL, and LCA, that changed 3-fold or more in concentration between normal and breast cancer patient plasma. Although the number of cancer patients examined was too small to validate cancer marker candidates, they are clearly worth examining in a larger, more diverse patient population.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available